Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepato Cellular Carcinoma (HCC)”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Not applicableLooking for participantsNCT06960863
What this trial is testing

Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Tanta University 80
Not applicableNot Yet RecruitingNCT06894524
What this trial is testing

Retrospective Clinical Validation of HepatoPredict

Who this might be right for
Hepato Cellular Carcinoma (HCC)Liver ResectionLiver Transplantation
Ophiomics 200
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Large-scale testing (Phase 3)Looking for participantsNCT07302919
What this trial is testing

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
University Hospital, Basel, Switzerland 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07494435
What this trial is testing

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

Who this might be right for
Hepato Cellular Carcinoma (HCC)Renal Cell Cancer
Zhejiang Haichang Biotech Co., Ltd. 230
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07487662
What this trial is testing

TACE or Ablation Combined With Sintilimab and Ipilimumab N01 as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With Intermediate-High Recurrence Risk

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Sun Yat-sen University 105
Not applicableLooking for participantsNCT07142213
What this trial is testing

Effect and Mechanism of ALPPS Operation on Liver Regeneration

Who this might be right for
Hepato Cellular Carcinoma (HCC)Hepatobiliary CancersLiver Cancer+1 more
Haitao Zhao, MD 50
Not applicableUnknownNCT05494853
What this trial is testing

Novel Biomarker Assay for Biomarker Assay for HCC Detection

Who this might be right for
Hepato-cellular Carcinoma
Genetron Health 200
Not applicableLooking for participantsNCT07393074
What this trial is testing

PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepato Cellular CarcinomaCirrhosisAutonomic Nervous System+1 more
Hospices Civils de Lyon 100
Large-scale testing (Phase 3)Study completedNCT00858871
What this trial is testing

First Line Hepato Cellular Carcinoma (HCC)

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Bristol-Myers Squibb 1,714
Testing effectiveness (Phase 2)Looking for participantsNCT07536789
What this trial is testing

Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06742424
What this trial is testing

PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC

Who this might be right for
Hepato Cellular Carcinoma (HCC)
West China Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT07489976
What this trial is testing

IIT2025-03-YANG-LIFT-HCC

Who this might be right for
Hepato Cellular Carcinoma
Ju Dong Yang 41
Large-scale testing (Phase 3)Not Yet RecruitingNCT07461675
What this trial is testing

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Who this might be right for
Hepato Cellular Carcinoma (HCC)Immunotherapy
University of Geneva, Switzerland 30
Testing effectiveness (Phase 2)Looking for participantsNCT07328009
What this trial is testing

A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 350
Not applicableStudy completedNCT07207304
What this trial is testing

Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes

Who this might be right for
Hepato-cellular CarcinomaNeutrophil Extracellular Trap FormationAnesthesia+1 more
Iuliu Hatieganu University of Medicine and Pharmacy 153
Large-scale testing (Phase 3)Looking for participantsNCT07267806
What this trial is testing

Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC

Who this might be right for
Hepato Cellular Carcinoma (HCC)Chemotherapy Effect
Linhui Peng 326
Testing effectiveness (Phase 2)Looking for participantsNCT07560566
What this trial is testing

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Who this might be right for
Hepato Cellular Carcinoma (HCC)Hand Foot Skin Syndrome
National Taiwan University Hospital 39
Testing effectiveness (Phase 2)Looking for participantsNCT07276100
What this trial is testing

Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab

Who this might be right for
Hepato Cellular Carcinoma (HCC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 15
Load More Results